Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 4
Submit an article Journal homepage
113
Views
0
CrossRef citations to date
0
Altmetric
Correspondence

Rebuttal and response to: “The efficacy and tolerability issue of generics of imatinib in the treatment of chronic myeloid leukemia: do generics really jeopardize patient safety?” by Ahmet Emre Eskazan, Muhlis Cem Ar and Teoman Soysal

Alaa Fadhil AlwanThe National Center of Hematology, Baghdad, IraqCorrespondence[email protected]
Page 1181 | Published online: 20 Aug 2014
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
"Rebuttal and response to: “The efficacy and tolerability issue of generics of imatinib in the treatment of chronic myeloid leukemia: do generics really jeopardize patient safety?” by Ahmet Emre Eskazan, Muhlis Cem Ar and Teoman Soysal." Leukemia & Lymphoma, 56(4), p. 1181

Potential conflict of interest:

A disclosure form provided by the author is available with the full text of this article at www.informahealthcare.com/lal.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.